Examining a stock’s 52-week price history, encompassing its low and high prices, can reveal much about its existing condition and potential future trajectory. Ginkgo Bioworks Holdings Inc’s current trading price is -40.28% away from its 52-week high, while its distance from the 52-week low is 35.71%. The stock’s price range over this period has fluctuated between $1.12 and $2.55. The company, operating within the financial sector, had a trading volume of approximately 12.22 million for the day, which was noticeably lower than the average daily share volume of 19.92 million over the last 3 months.
The stock price for Ginkgo Bioworks Holdings Inc (DNA) currently stands at $1.52. The stock experienced a substantial increase in the last session, hitting $1.52 after starting at $1.48. The stock’s lowest price was $1.43 before closing at $1.46.
Elon Musk just Triggered a BOOM in These Stocks
Something strange is happening in the stock market…. This select group of stocks are going absolutely bananas. And it's all because of Elon Musk. Get your copy of "Top 5 Tech Stocks to Buy in 2024"
Click Here to Download the FREE Report.
Sponsored
Ginkgo Bioworks Holdings Inc ‘s stock market performance has been somewhat erratic. The company’s stock reached a 1-year high price of $2.55 on 07/19/23, while the lowest value for the same period was recorded at $1.12 on 05/03/23.
Exploring Financial Performance and Market Capitalization: A Comprehensive Analysis
Ginkgo Bioworks Holdings Inc (DNA) has experienced a quarterly decline of -8.43% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 2.97B and boasts a workforce of 1292 employees.
Analyzing Trading Volume and Moving Average Trends
Based on Barchart.com data, the company’s moving average over the 100-day period was 1.8365, with a change in price of -0.3000. Similarly, Ginkgo Bioworks Holdings Inc recorded 20,563,420 in trading volume during the last 100 days, posting a change of -16.48%.
Understanding Ticker ‘s Debt-to-Equity Ratio: An Analysis
The debt-to-equity (D/E) ratio serves as an important indicator of a company’s financial stability and market position. By dividing a company’s total liabilities by its shareholders’ equity, the D/E ratio reveals the degree to which a company relies on debt to finance assets compared to its shareholders’ equity. At the time of writing, the total D/E ratio for DNA stands at 0.32. Similarly, the long-term debt-to-equity ratio is also 0.32.
DNA Stock Stochastic Average
Today’s raw stochastic average for Ginkgo Bioworks Holdings Inc over the last 50 days is 31.46%.This indicates a decrease from the raw stochastic average of the past 20 days, which was 62.37%. Moreover, the company’s Stochastic %K and %D values for the last 20 days were 60.98% and 52.13%, respectively.
DNA Stock Price Performance Analysis
The stock price performance this year has been a mixed bag, which means people have different opinions about whether it’s been good or bad. Some may see it as optimistic, while others may view it as pessimistic. This year’s metric has recorded a Price decrease of -10.06%. However, over the past six months, we’ve seen a weaker performance of 18.75%. The price of DNA leaped by -2.56% over the last 30 days. And in the last five days, it has surged by 18.75%.
